The Future of Dermatology
Join Dr. Faranak Kamangar, MD, every week as she chats with various guests about the future of dermatology. Each week, Dr. Kamangar and her guests cover topics from psoriasis, to eczema, to skin care, to AI, and more. Whether you’re a doctor or a patient, these episodes provide valuable information about your skin and how to navigate the world of dermatology.
Listen on:
Episodes
Tuesday Dec 03, 2024
Tuesday Dec 03, 2024
Summary
Dr. Faranak Kamangar and Sam Kamangar chat about the TEDx Sandhill Road Women event, highlighting the importance of storytelling, mentorship, and community support in empowering women. They discuss their experiences and insights on engaging the younger generation, the role of men in supporting women's empowerment, the significance of language in professional settings, and the challenges women face in health and legal access. This discussion emphasizes the need for continuous growth, collaboration, and the sharing of ideas to foster a supportive environment for future generations.
Do you know someone who has a story to share? Let's connect! thefutureofdermatology@gmail.com
They could be a guest on our next podcast or at our next TEDx event.
Watch the full TEDx presentations!
Dr. Faranak Kamangar: https://youtu.be/XAcCahWkKiQ?si=KOw8eo9X-VmbrBC4
Dr. Julie Letsinger: https://youtu.be/BKpRZHp1u44?si=C1IybJtRiJFoZL-P
Nora Engstrom: https://youtu.be/ZP64ZhULyBI?si=ewmVSApitKs7mURn
Dr. Leah Millheiser: https://youtu.be/hvkHeb7_Q6w?si=LrCevtnksLrMhOg5
Melissa Bowdoin: https://youtu.be/SbSa81utzJE?si=Ur4J-oRFVxdENMo5
Dr. Kathy Fields: https://youtu.be/SbSa81utzJE?si=Ur4J-oRFVxdENMo5
Takeaways
The TEDx format is an effective way for professionals to share ideas.
Storytelling plays a crucial role in shaping the next generation. - Engaging young people in discussions is essential for their development.
Men's support is vital in women's empowerment initiatives.
Language proficiency can significantly impact professional success.
Access to legal resources is critical for personal and professional growth.
Empowering young female leaders is essential for future progress.
Navigating change requires personal growth and stepping out of comfort zones.
Menopause should be openly discussed to educate and empower women.
Collaboration and sharing ideas can lead to greater success.
Chapters
00:00 - Introduction to the Future of Dermatology Podcast
00:52 - The Importance of Executive Presence
03:38 - Role Models and Storytelling in Women's Lives
05:30 - Engaging the Younger Generation
07:17 - The Power of Diverse Communities
09:10 - Men Supporting Women in Professional Spaces
11:05 - Breaking Taboos in Women's Health Discussions
12:21 - Recap of TEDx Talks
12:40 - AI and Language in Dermatology
16:09 - Dr Kathy Fields: A Dermatology Pioneer
19:12 - Nora Engstrom: Access to Law for Women
21:23 - Melissa Bowdoin: Empowering Future Leaders
25:16 - Dr. Julie Letsinger: Navigating Change
26:35 - Dr. Leah Millheiser: Menopause and Women's Health
29:22 - The Impact of Education and Experience
32:11 - The Importance of Teamwork and Support
34:29 - Encouraging the Next Generation
37:10 - Looking Ahead: Future TEDx Events
Tuesday Nov 26, 2024
Tuesday Nov 26, 2024
Summary
In this episode of the Future of Dermatology podcast, Dr. Faranak Kamangar discusses the intersection of artificial intelligence and dermatology with Pedram Abrari, a leading expert in AI and technology. They explore the complexities of integrating AI into medical practice, the potential benefits and challenges of large language models, and the importance of building trust between physicians and technology. The conversation highlights practical applications of AI in diagnostics, patient care, and administrative tasks, while addressing the historical mistrust of technology in medicine. The episode concludes with insights on the future of AI in healthcare and the necessity for physicians to adapt to these advancements.
Pedram Abrari, CTO of Pramata, is a proven technology leader specialized in highly scalable cloud platforms. Entrepreneur who excels at assessing the strengths and weaknesses of technology, competitive analysis, tracking market trends and strategic technology planning. Experienced at building world-class engineering teams and fostering high productivity. Believes quality begins with the inception of the idea, sound design, and proper architecture. Works tirelessly to pave the way for engineering teams to overachieve.
Takeaways
AI is a game-changing technology that can enhance medical practice.
The relationship between physicians and technology has historically been complicated.
Large language models have the potential to mimic human intelligence.
AI can help connect the dots in diagnosing rare diseases.
Trust in AI will grow as its capabilities are proven over time.
AI can significantly reduce administrative burdens in healthcare.
The adoption of AI can improve patient care and outcomes.
Physicians need to understand AI's strengths and weaknesses.
AI will not replace doctors but will serve as an assistant.
The future of healthcare will involve a collaborative approach between AI and medical professionals.
Chapters
00:00 - Introduction to AI in Dermatology
02:52 - Understanding Large Language Models
06:13 - The Relationship Between Physicians and Technology
09:03 - AI's Role in Medical Diagnostics
11:52 - The Future of AI in Healthcare
15:07 - Technology Adoption and Trust Issues
17:58 - Practical Applications of AI in Dermatology
21:05 - Overcoming Challenges in Prior Authorization
23:49 - Conclusion and Future Perspectives
Tuesday Nov 19, 2024
Tuesday Nov 19, 2024
Summary
From the 2024 SF Derm Society Annual Meeting, dermatologist, Dr. David Fiorentino discuss the significance of auto-antibodies in diagnosing dermatomyositis. He explores various phenotypes associated with the disease, emphasizing the importance of recognizing specific symptoms and patient presentations to improve diagnostic accuracy and patient outcomes. The conversation highlights the need for dermatologists to be aware of the complexities of dermatomyositis and the potential for severe complications if not diagnosed and treated promptly.
Takeaways
The six groups of DM specific antibodies are crucial for diagnosis.
Understanding phenotypes can enhance diagnostic capabilities.
NDA5 antibodies are linked to severe interstitial lung disease.
Dermatomyositis can present without typical skin symptoms.
Early intervention is critical for patients with NXP2 antibodies.
Patients may present with atypical symptoms that require careful assessment.
Auto-antibodies can guide treatment decisions in dermatology.
Recognizing the signs of dermatomyositis can prevent severe outcomes.
Collaboration among dermatologists is essential for patient care.
Continuous education in dermatology is vital for improving patient outcomes.
Chapters
00:00 - Introduction to the Future of Dermatology Podcast
00:58 - Understanding Auto-Antibodies in Dermatomyositis
03:13 - Diagnostic Approaches in Dermatomyositis
05:48 - Identifying Phenotypes in Dermatomyositis Patients
08:57 - Conclusion and Future Directions
Tuesday Nov 12, 2024
Tuesday Nov 12, 2024
Summary
In this episode of the Future of Dermatology podcast, Dr. Farah Kamangar interviews Dr. Paradi Mirmirani, MD, a leading expert in hair disorders. They discuss the latest advancements in treating hair loss, particularly focusing on frontal fibrosing alopecia and scarring alopecia. Dr. Mirmirani shares her treatment algorithms, emphasizing the importance of removing triggers and using innovative therapies like oral minoxidil and JAK inhibitors. The conversation highlights the evolving landscape of dermatology and the exciting future of hair loss treatments.
Dr. Mirmirani's paper that is spoken about in this podcast will be published on November 20th, 2024.
Takeaways
Dr. Mirmirani is a leading expert in hair disorders.
Frontal fibrosing alopecia is increasingly common.
Removing environmental triggers can significantly improve patient outcomes.
Dutasteride is preferred over finasteride for treating FFA.
Oral minoxidil is an effective treatment for hair loss.
Dermatoscopy is essential for assessing hair loss conditions.
New treatments for alopecia areata are now FDA-approved.
Patient education is crucial for effective treatment.
The landscape of hair loss treatments is rapidly evolving.
Future research will focus on personalized treatment options for hair disorders.
Chapters
00:00 - Introduction to Dermatology and Dr. Mirmirani's Expertise
02:09 - Frontal Fibrosing Alopecia: Treatment Approaches
10:24 - Innovative Therapies for Scarring Alopecia
18:46 - Future of Hair Loss Treatments and Research
Tuesday Nov 05, 2024
Tuesday Nov 05, 2024
Summary
Dr. Mehdi Rashighi, MD, discusses groundbreaking research in dermatology focusing on autoimmune skin diseases. The conversation delves into multiomics research, the role of interferons in skin diseases, and the impact of UV exposure on conditions like cutaneous lupus and dermatomyositis. The episode highlights the importance of understanding cytokine signatures and the potential for new treatments targeting specific immune cells.
Takeaways
The SFDerm 2024 meeting showcased significant advancements in dermatology.
Multiomics research is crucial for understanding autoimmune skin diseases.
Type one interferon plays a key role in cutaneous lupus and dermatomyositis.
Cytokine signatures can help identify new treatment targets.
Plasmacytoid dendritic cells are important in the pathogenesis of lupus.
UV exposure can exacerbate skin diseases like lupus and dermatomyositis.
Clinical trials are exploring monoclonal antibodies against interferons.
Understanding photosensitivity is vital for managing lupus patients.
Research is ongoing to better understand the immune response in skin diseases.
Chapters
00:00 - Introduction to the Future of Dermatology Podcast
00:56 - Exploring Multiomics in Dermatology Research
02:53 - Understanding Interferon Signatures in Skin Diseases
05:58 - Photosensitivity in Cutaneous Lupus and Dermatomyositis
Tuesday Oct 29, 2024
Tuesday Oct 29, 2024
Summary
In this episode of The Future of Dermatology Podcast, Dr. Faranak Kamangar discusses hyperhidrosis, a common condition characterized by excessive sweating. The conversation covers the causes, prevalence, and various treatment options available, including topical treatments, botulinum toxin injections, oral medications, and advanced technologies like ionophoresis and miradry. Dr. Kamangar emphasizes the importance of patient education and setting realistic expectations for treatment outcomes.
Takeaways
Hyperhidrosis is often diagnosed by patients before seeing a doctor.
The condition can be debilitating and affects various aspects of life.
Most cases of hyperhidrosis are primary, with few secondary causes.
Topical antiperspirants are the first line of treatment.
Setting expectations is crucial for patient satisfaction with treatments.
Botulinum toxin is effective but can be painful for patients.
Oral medications can be used but have contraindications.
Ionophoresis is a viable option for some patients.
Emerging technologies like microneedling for botulinum toxin show promise.
Patient education is key to managing hyperhidrosis effectively.
Chapters
00:00 - Introduction to Hyperhidrosis
02:45 - Understanding Hyperhidrosis: Causes and Prevalence
06:00 - First-Line Treatments for Hyperhidrosis
09:13 - Advanced Treatment Options: Botulinum Toxin and Microneedling
11:51 - Oral Medications and Ionophoresis
15:06 - Injectable Treatments and Patient Management
17:47 - Emerging Technologies and Future Directions in Treatment
Tuesday Oct 22, 2024
Tuesday Oct 22, 2024
Summary
From the 2024 Annual SF Dermatology Society sessions, Dr. Iltefat Hamzavi shares insights on vitiligo, its psychosocial impacts, and the pathophysiology behind the condition. The session emphasizes the need for effective treatment strategies and the importance of patient well-being in managing skin conditions.
Takeaways
Dermatology is a community-focused specialty.
The VASI score is crucial for assessing vitiligo severity.
Vitiligo has a significant psychosocial impact on patients.
Younger patients with vitiligo show higher rates of depression.
Effective treatment of vitiligo requires time and patience.
Counseling patients is essential for successful treatment outcomes.
The face is the most responsive area for vitiligo treatment.
Oxidative stress plays a key role in vitiligo pathophysiology.
A multi-faceted approach is necessary for treating vitiligo.
Future dermatology meetings will continue to address these important topics.
Chapters
00:00 - Introduction to the Dermatology Podcast
01:58 - The Importance of Community in Dermatology
03:25 - Understanding the Impact of Vitiligo
06:45 - Pathophysiology and Treatment of Vitiligo
10:09 - Conclusion and Future Directions in Dermatology
Tuesday Oct 15, 2024
Tuesday Oct 15, 2024
Summary
This The Future of Dermatology Podcast focuses on recent advancements in the treatment of vitiligo, particularly highlighting the role of Afamelanotide in clinical trials. Dr. Kamangar includes insights from the SF Derm 2024 Annual Meeting, the mechanisms of vitiligo, and the potential of Afamelanotide to aid in repigmentation without affecting the immune system. Clinical trial results and patient outcomes are also discussed, emphasizing the importance of this treatment for patients with darker skin types.
Takeaways
Vitiligo treatments have traditionally focused on the immune system.
Afamelanotide aims to boost repigmentation without immune suppression.
The study is a phase three trial comparing Afamelanotide with narrowband UVB.
Initial results show promise for Fitzpatrick skin types four to six.
The treatment is suitable for adolescents and adults aged 12 and up.
Photos from trials indicate significant repigmentation in patients. - Afamelanotide has a good safety profile based on previous treatments.
The drug is being studied for its broader dermatological applications. - There are concerns about unregulated versions of Afamelanotide in the market.
Awareness of Afamelanotide is crucial for dermatologists.
Chapters
00:00 - Introduction to the Future of Dermatology Podcast
01:20 - Exploring Vitiligo Treatments and Research
03:10 - Afamelanotide: A New Hope for Repigmentation
05:37 - Clinical Results and Implications of Afamelanotide